doi:

DOI: 10.3724/SP.J.1008.2011.01357

Academic Journal of Second Military Medical University (第二军医大学学报) 2011/31:12 PP.1357-1360

Epithelial-mesenchymal transition and cancer stem cells in tumor metastasis


Abstract:
The epithelial-mesenchymal transition (EMT) is characterized by absence of epithelial phenotype and acquiring of mesenchymal properties. EMT participates not only in normal embryonic development,wound healing and tissue reconstruction,but also in various pathologic processes,including fibrosis and carcinogenesis. EMT can facilitate the invasion and metastasis of cancer cells to distant tissues,and confer the metastatic cancer cells self-renewal ability of stem cells,contributing to macroscopical metastasis formation and multiple resistance to treatment. Recent studies have revealed that several transcription factors,signaling pathways,microRNAs and microenvironment components are involved in this process. Here we summarize the recent progress on the roles of EMT and cancer stem cells in tumor metastasis,hoping to provide new insights in target therapy of tumor metastasis and recurrence.

Key words:neoplasms,epithelial-mesenchymal transitions,cancer stem cells,metastasis

ReleaseDate:2014-07-21 16:05:36

Funds:Undergraduate Innovation Ability Fund of Second Military Medical University (MS2010099)



[1] Weigelt B,Peterse J L,van’t Veer L J. Breast cancer metastasis:markers and models[J].Nat Rev Cancer,2005,5:591-602.

[2] Greenburg G,Hay E D.Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells[J].J Cell Biol,1982,95:333-339.

[3] Gavert N,Ben-Ze’ev A.Epithelial-mesenchymal transition and the invasive potential of tumors[J].Trends Mol Med,2008,14:199-209.

[4] Voulgari A,Pintzas A.Epithelial-mesenchymal transition in cancer metastasis:mechanisms,markers and strategies to overcome drug resistance in the clinic[J].Biochim Biophys Acta,2009,1796:75-90.

[5] Clarke M F,Dick J E,Dirks P B,Eaves C J,Jamieson C H,Jones D L,et al.Cancer stem cells-perspectives on current status and future directions:AACR Workshop on cancer stem cells[J].Cancer Res,2006,66:9339-9344.

[6] Takahashi K,Yamanaka S.Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factots[J].Cell,2006,126:663-676.

[7] Baumann M,Krause M,Hill R.Exploring the role of cancer stem cells in radioresistance[J].Nat Rev Cancer,2008,8:545-554.

[8] Luzzi K J,MacDonald I C,Schmidt E E,Kerkvliet N,Morris V L,Chambers A F,et al.Multistep nature of metastatic inefficiency:dormancy of solitary cells after successful extravasation and limited survival of early micrometastases[J].Am J Pathol,1998,153:865-873.

[9] Paget S.The distribution of secondary growths in cancer of the breast.1889[J].Cancer Metastasis Rev,1989,8:98-101.

[10] Liu R,Wang X,Chen G Y,Dalerba P,Gurney A,Hoey T,et al.The prognostic role of a gene signature from tumorigenic breast-cancer cells[J].N Engl J Med,2007,356:217-226.

[11] Balic M,Lin H,Young L,Hawes D,Giuliano A,McNamara G,et al.Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype[J].Clin Cancer Res,2006,12:5615-5621.

[12] Yang Z F,Ngai P,Ho D W,Yu W C,Ng M N,Lau C K,et al.Identification of local and circulating cancer stem cells in human liver cancer[J].Hepatology,2008,47:919-928.

[13] Nishii T,Yashiro M,Shinto O,Sawada T,Ohira M,Hirakawa K.Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma[J].Cancer Sci,2009,100:1397-1402.

[14] Hermann P C,Huber S L,Herrler T,Aicher A,Ellwart J W,Guba M,et al.Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer[J].Cell Stem Cell,2007,1:313-323.

[15] Brabletz T,Jung A,Spaderna S,Hlubek F,Kirchner T.Opinion:migrating cancer stem cells-an integrated concept of malignant tumour progression[J].Nat Rev Cancer,2005,5:744-749.

[16] Mani S A,Guo W,Liao M J,Eaton E N,Ayyanan A,Zhou A Y,et al.The epithelial-mesenchymal transition generates cells with properties of stem cells[J].Cell,2008,133:704-715.

[17] Hwang W L,Yang M H,Tsai M L,Lan H Y,Su S H,Chang S C,et al.SNAIL regulates interleukin-8 expression,stem cell-like activity,and tumorigenicity of human colorectal carcinoma cells[J].Gastroenterology,2011,141:279-291.

[18] Massagué J.TGF beta in cancer[J].Cell,2008,134:215-230.

[19] Shipitsin M,Campbell L L,Argani P,Weremowicz S,Bloushtain-Qimron N,Yao J,et al.Molecular definition of breast tumor heterogeneity[J].Cancer Cell,2007,11:259-273.

[20] Iliopoulos D,Polytarchou C,Hatziapostolou M,Kottakis F,Maroulakou I G,Struhl K,et al.MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells[J].Sci Signal,2009,2:ra62.

[21] Penuelas S,Anido J,Prieto-Sanchez R M,Folch G,Barba I,Cuartas I,et al.TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma[J].Cancer Cell,2009,15:315-327.

[22] Varnat F,Duquet A,Malerba M,Zbinden M,Mas C,Gervaz P,et al.Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth,recurrence,metastasis and stem cell survival and expansion[J].EMBO Mol Med,2009,1(6-7):338-351.

[23] Wang Z,Li Y,Kong D,Banerjee S,Ahmad A,Azmi A S,et al.Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway[J].Cancer Res,2009,69:2400-2407.

[24] Kurrey N K,Jalgaonkar S P,Joglekar A V,Ghanate A D,Chaskar P D,Doiphode R Y,et al.Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells[J].Stem Cells,2009,27:2059-2068.

[25] Moody S E,Perez D,Pan T C,Sarkisian C J,Portocarrero C P,Sterner C J,et al.The transcriptional repressor Snail promotes mammary tumor recurrence[J].Cancer Cell,2005,8:197-209.

[26] Rosivatz E,Becker I,Specht K,Fricke E,Luber B,Busch R,et al.Differential expression of the epithelial-mesenchymal transition regulators snail,SIP1,and twist in gastric cancer[J].Am J Pathol,2002,161:1881-1891.

[27] Yang J,Mani S A,Donaher J L,Ramaswamy S,Itzykson R A,Come C,et al.Twist,a master regulator of morphogenesis,plays an essential role in tumor metastasis[J].Cell,2004,117:927-939.

[28] Wellner U,Schubert J,Burk U C,Schmalhofer O,Zhu F,Sonntag A,et al.The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs[J].Nat Cell Biol,2009,11:1487-1495.

[29] Yu M,Smolen G A,Zhang J,Wittner B,Schott B J,Brachtel E,et al.A developmentally regulated inducer of EMT,LBX1,contributes to breast cancer progression[J].Genes Dev,2009,23:1737-1742.

[30] Evdokimova V,Tognon C,Ng T,Ruzanov P,Melnyk N,Fink D,et al.Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition[J].Cancer Cell,2009,15:402-415.

[31] McCoy E L,Iwanaga R,Jedlicka P,Abbey N S,Chodosh L A,Heichman K A,et al.Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition[J].J Clin Invest,2009,119:2663-2677.

[32] Park S M,Gaur A B,Lengyel E,Peter M E.The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2[J].Genes Dev,2008,22:894-907.

[33] Tavazoie S F,Alarcón C,Oskarsson T,Padua D,Wang Q,Bos P D,et al.Endogenous human microRNAs that suppress breast cancer metastasis[J].Nature,2008,451:147-152.

[34] Ma L,Teruya-Feldstein J,Weinberg R A.Tumour invasion and metastasis initiated by microRNA-10b in breast cancer[J].Nature,2007,449:682-688.

[35] Marson A,Levine S S,Cole M F,Frampton G M,Brambrink T,Johnstone S,et al.Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells[J].Cell,2008,134:521-533.

[36] Shimono Y,Zabala M,Cho R W,Lobo N,Dalerba P,Qian D,et al.Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells[J].Cell,2009,138:592-603.

PDF